Dr. Paul Monga is an Academic Physician with an interest in furthering our understanding of many aspects of liver health and disease. His lab has been focused on elucidating the cellular and molecular underpinnings of hepatic pathophysiology, especially of liver development, repair, and tumorigenesis. His research has been consistently funded by NIH and industry since 2003 and he is currently PI/MPI on three R01s. He has published 230 manuscripts and reviews in peer-reviewed journals like Hepatology, Gastroenterology, Journal of Hepatology, American Journal of Pathology, Cell Metabolism, Cell Reports, Cell Reports Medicine, Nature, and others. Dr. Monga has been inducted into ASCI and AAP and has received other award and honors. Currently, he serves as the president of the American Society of Investigative Pathology. He is also the editor-in-chief for the Seminars in Liver Disease and associate/consulting editor for Science Signaling, Annual Reviews in Pathology and JCI Insights. 

Dr. Monga holds an MD degree from Dayanand Medical College and Hospital, Ludhiana, and Punjab University, Chandigarh, India. He did his Postdoctoral Fellowships in Gastroenterology and Molecular Biology at the Veterans Association Medical Center in Washington, DC from 1996-1999. He joined the Department of Pathology at the University of Pittsburgh as a Research Associate in 1999 and was promoted to faculty in 2001. He rose through the ranks and became the chief and vice chair of the division of Experimental Pathology and also served as assistant dean and codirector of the Medical Scientist Training Program. In 2024, Dr. Monga was appointed as the Director of the new Organ Pathobiology and Therapeutics Institute and as an Associate Dean of Research in the School of Medicine. He is currently a Professor of Pharmacology and Medicine, and a Senior Vice Chancellor Endowed Chair in Pathobiology and Therapeutics. He is also the founding director of the Pittsburgh Liver Research Center which is funded by NIDDK as a P30 since 2019 under his leadership. He is also the program director of the Cellular Approaches to Tissue Engineering and Regeneration (CATER) Training Program, a T32 funded by NIBIB.